Sign Up to like & get
recommendations!
0
Published in 2019 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofz301
Abstract: Abstract Background HIV-associated cardiovascular disease (CVD) risk in combination antiretroviral therapy (cART)–treated perinatally HIV-infected patients (PHIV+) remains unknown due to the young age of this population. Lipoprotein(a) (Lp(a)) has been established as an independent causal…
read more here.
Keywords:
phiv children;
ethnicity;
ethnicity matched;
cart treated ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "Medicine"
DOI: 10.1097/md.0000000000027157
Abstract: Abstract Ovarian dysfunction and lower circulating anti-Müllerian hormone (AMH) feature women living with HIV (WLWH). Because treated human immunodeficiency virus (HIV) infection is characterized by a pro-inflammatory/oxidative phenotype resulting in residual comorbidity, we sought to…
read more here.
Keywords:
cart treated;
living hiv;
hiv;
women living ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "AIDS Research and Treatment"
DOI: 10.1155/2023/1566001
Abstract: Background There is an increasing prevalence of cardiovascular diseases (CVDs) and risk factors in HIV patients as the levels of AIDS-related mortality and morbidity decrease. Metabolic syndrome (MetS) is the accumulation of various CVD risk…
read more here.
Keywords:
treated hiv;
hiv;
cart hiv;
cart treated ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "International Journal of General Medicine"
DOI: 10.2147/ijgm.s356771
Abstract: Purpose To investigate factors involved in T-cell depletion in combination antiretroviral therapy (cART)-treated human immunodeficiency virus 1 (HIV-1)-positive patients. Patients and Methods 29 HIV-1-positive patients were enrolled. The CD4+, CD8+ T cell subsets and CD56dim…
read more here.
Keywords:
cart treated;
cell;
group;
cell depletion ... See more keywords